Editorial: The Future of Randomized Clinical Trials p.4-5

A Pilot Open Study of Long Term High Dose
Creatine Augmentation in Patients with Treatment
Resistant Negative Symptoms Schizophrenia
Uri Levental, MD, Yuly Bersudsky, MD, Tzvi Dwalatzky, MD, Vladimir Lerner, MD, Sophie Medina, MA, and Joseph Levine, MD p.6-11

Safety, Tolerability and Pharmacokinetics of
Open Label Sarcosine Added on to Anti-Psychotic
Treatment in Schizophrenia – Preliminary Study
Revital Amiaz, MD, Ilan Kent, MD, Katya Rubinstein, MA, Ben Ami Sela, PhD, Daniel Javitt, MD, PhD,
and Mark Weiser, MD p.12-16

Long-term Follow-up of MDD Patients Who
Respond to Deep rTMS: A Brief Report
Oded Rosenberg, MD, Limor Dinur Klein, MSc, Roman Gersner,PhD, Moshe Kotler, MD, Abraham Zangen, PhD,
and Pinhas Dannon,MD p.17-24

Suicides Among Persons with Psychiatric Hospitalizations
Nehama Goldberger, MSc, Ziona Haklai, MA, Inna Pugachova, MPH, and Itzhak Levav, MD, MSc p.25-32

Validation of the Hebrew and Arabic Versions of the Outcome Questionnaire (OQ-45)
Raz Gross, MD, MPH, Saralee Glasser, MA, David Elisha PhD, Orya Tishby PhD, Daria Madar Jacobson, MD,
Gila Levitan MPH, Michael J. Lambert, PhD, and Alexander M. Ponizovsky, MD, PhD p.33-39

Social Anxiety Disorder Comorbid with Schizophrenia: The Importance of Screening for This Underrecognized and Undertreated Condition
Katherine Moss Lowengrub, MD, Rafael Stryjer, MD, Moshe Birger, MD, and Iulian Iancu, MD p.40-46

Dissociative Reality and Dissociative Being in Therapy for Posttraumatic Patients
Jonathan Guez, PhD, Mali Hertzanu-Lati, MSW, Rachel Lev-Wiesel, PhD, and Stanley Rabin, PhD p.47-53

Cognitive Appraisal and Psychological Distress Among Patients with Irritable Bowel Syndrome
Menachem Ben-Ezra, PhD, Yaira Hamama-Raz, PhD, Sharon Palgi, MA, and Yuval Palgi, PhD p.54-60

Assessing Fears of Preschool Children with Nighttime Fears by a Parent Version of the Fear Survey Schedule for Preschool Children
Jonathan Kushnir, PhD, Doron Gothelf, MD, and Avi Sadeh, DsC p.61-66

LSD-associated “Alice in Wonderland Syndrome” (AIWS):
A Hallucinogen Persisting Perception
Disorder (HPPD) Case Report
Arturo G. Lerner, MD, and Shaul Lev Ran, MD p.67-69